Drug Shortage Report for PRIORIX-TETRA
| Report ID | 137979 |
| Drug Identification Number | 02297884 |
| Brand name | PRIORIX-TETRA |
| Common or Proper name | Combined measles, mumps, rubella and varicella vaccine, live, attenuated |
| Company Name | GLAXOSMITHKLINE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | MUMPS VIRUS VACCINE LIVE ATTENUATED MEASLES VIRUS VACCINE LIVE ATTENUATED RUBELLA VIRUS VACCINE LIVE ATTENUATED VARICELLA-ZOSTER VIRUS VACCINE LIVE ATTENUATED |
| Strength(s) | 25118.9CCID50 1000CCID50 1000CCID50 1995.2623CCID50 |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAMUSCULAR SUBCUTANEOUS INTRAMUSCULAR SUBCUTANEOUS |
| Packaging size | 10s |
| ATC code | J07BD |
| ATC description | VIRAL VACCINES |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2021-04-20 |
| Estimated end date | 2021-07-26 |
| Actual end date | 2021-07-20 |
| Shortage status | Resolved |
| Updated date | 2021-07-21 |
| Company comments | Supply unavailable |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v9 | 2021-07-21 | English | Compare |
| v8 | 2021-07-20 | French | Compare |
| v7 | 2021-07-20 | English | Compare |
| v6 | 2021-07-16 | French | Compare |
| v5 | 2021-07-16 | English | Compare |
| v4 | 2021-04-28 | French | Compare |
| v3 | 2021-04-28 | English | Compare |
| v2 | 2021-04-23 | French | Compare |
| v1 | 2021-04-23 | English | Compare |
Showing 1 to 9 of 9